AbbVie Inc. is 259.1x more valuable than Septerna, Inc. by market capitalization ($397.44 B vs $1.53 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | SEPN | ABBV |
|---|---|---|
| Market cap | $1.53 B | $397.44 B |
| US-listed rank | #2318 | #28 |
| Revenue (latest FY) | $45.95M | $61.16B |
| Net income (latest FY) | -$48.88M | $4.23B |
| Net margin | -106.4% | 6.9% |
| P/E (trailing FY) | - | 94.0 |
| SEC filings | 129 | 1,008 |
AbbVie Inc. is 259.1x more valuable than Septerna, Inc. by market capitalization ($397.44 B vs $1.53 B).
In their latest fiscal years, Septerna, Inc. reported $45.95M in revenue while AbbVie Inc. reported $61.16B.
Full pages: Septerna, Inc. and AbbVie Inc., or browse the full rankings.